## **Core Concept**
The question revolves around the risk of progression from complex hyperplasia with atypia to endometrial malignancy in postmenopausal women. This involves understanding the classification and natural history of endometrial hyperplasia, particularly the role of cellular atypia in predicting malignant transformation.

## **Why the Correct Answer is Right**
Complex hyperplasia with atypia, also known as atypical complex hyperplasia or endometrial intraepithelial neoplasia (EIN) with cytological atypia, represents a precancerous condition of the endometrium. The presence of cellular atypia significantly increases the risk of progression to endometrial carcinoma. Studies have shown that the risk of progression from atypical complex hyperplasia to endometrial cancer is approximately 29-40% if left untreated. This high-risk nature necessitates careful management, often involving hysterectomy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option suggests a much lower risk than what is established in medical literature for atypical complex hyperplasia.
- **Option B:** Similarly, this option underestimates the risk associated with atypical complex hyperplasia progressing to malignancy.
- **Option D:** This option overestimates the risk compared to the commonly cited figures in medical literature.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the presence of atypia in endometrial hyperplasia significantly increases the risk of progression to endometrial cancer. In postmenopausal women, where the risk of endometrial cancer may already be higher due to factors like unopposed estrogen exposure, identifying and managing atypical hyperplasia is critical. The FIGO (International Federation of Gynecology and Obstetrics) and other gynecological oncology guidelines often recommend hysterectomy for the definitive management of atypical complex hyperplasia due to its high risk of progression to cancer.

## **Correct Answer:** . 30%